ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
ekipsp
|
87 |
24K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
87
|
24K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
ekipsp
|
87 |
24K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
87
|
24K
|
2
|
|
IPOs
|
|
Re:
Aegros Pre IPO and IPO later
|
|
ekipsp
|
128 |
154K |
0 |
19/07/24 |
19/07/24 |
IPOs
|
128
|
154K
|
0
|
|
ASX - By Stock
|
AL3 |
Re:
General Discussion
|
|
ekipsp
|
302 |
104K |
0 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
302
|
104K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
ekipsp
|
72 |
25K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
72
|
25K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
ekipsp
|
245 |
69K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
245
|
69K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
ekipsp
|
245 |
69K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
245
|
69K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
ekipsp
|
245 |
69K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
245
|
69K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
ekipsp
|
245 |
69K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
245
|
69K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
ekipsp
|
42 |
13K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
42
|
13K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
ekipsp
|
118 |
35K |
0 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
118
|
35K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
ekipsp
|
118 |
35K |
4 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
118
|
35K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
ekipsp
|
118 |
35K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
118
|
35K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
ekipsp
|
118 |
35K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
118
|
35K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
ekipsp
|
118 |
35K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
118
|
35K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
ekipsp
|
55 |
23K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
55
|
23K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
ekipsp
|
67 |
24K |
0 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
67
|
24K
|
0
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
ekipsp
|
79 |
76K |
1 |
15/10/23 |
15/10/23 |
Charts
|
79
|
76K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Patient Demand
|
|
ekipsp
|
5 |
3.7K |
0 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
5
|
3.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
ekipsp
|
31 |
12K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Patient Demand
|
|
ekipsp
|
5 |
3.7K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
5
|
3.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
ekipsp
|
50 |
15K |
0 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
50
|
15K
|
0
|
|
ASX - By Stock
|
OSL |
Patient Demand
|
|
ekipsp
|
5 |
3.7K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
5
|
3.7K
|
1
|
|
ASX - By Stock
|
OSL |
Director's fees
|
|
ekipsp
|
0 |
696 |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
0
|
696
|
0
|
|